Literature DB >> 17941915

Atopic features of cough variant asthma and classic asthma with wheezing.

M Takemura1, A Niimi, H Matsumoto, T Ueda, M Yamaguchi, H Matsuoka, M Jinnai, K Chin, M Mishima.   

Abstract

BACKGROUND: Cough variant asthma is a phenotype of asthma solely presenting with coughing. It involves airway inflammation and remodelling as does classic asthma with wheezing, and a subset of patients may progress to classic asthma. The atopic features of cough variant asthma remain unclear.
OBJECTIVE: To compare atopic features between patients with cough variant asthma and those with classic asthma, and to examine the possible correlation of these features with the future development of wheezing in the former group.
METHODS: Total and specific IgE levels of seven common aeroallergens [house dust mite (HDM), Gramineae/Japanese cedar/weed pollens, moulds, cat/dog dander] were examined in 74 cough variant asthma patients and in 115 classic asthma patients of varying severity. Forty of the former patients were prospectively observed for 2 years to determine whether cough variant asthma progressed to classic asthma despite inhaled corticosteroid treatment.
RESULTS: Patients with classic asthma had higher total IgE (P<0.0001), larger numbers of sensitized allergens (P=0.03), and higher rates of sensitization to dog dander (24% vs. 3%, P<0.0001), HDM (46% vs. 28%, P=0.02), and moulds (17% vs. 7%, P=0.047) than did patients with cough variant asthma. Wheezing developed in six (15%) patients with cough variant asthma, who were sensitized to larger numbers of allergens (P=0.02) and had higher rates of sensitization to HDM (P=0.01) and dog dander (P=0.02) than the 34 patients in whom wheezing did not develop. Among the patients with classic asthma, total and specific IgE variables were similar in the subgroup with mild disease (n=60) and the subgroup with moderate-to-severe disease (n=55), as reported previously.
CONCLUSIONS: Atopy may be related to the development of wheezing in patients with cough variant asthma. To prevent the progression of cough variant asthma to classic asthma, avoidance of relevant allergens may be essential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941915     DOI: 10.1111/j.1365-2222.2007.02848.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Cough in asthma is due to eosinophilic airway inflammation: a pro/con debate.

Authors:  Akio Niimi; Christopher E Brightling; Peter V Dicpinigaitis
Journal:  Lung       Date:  2013-12-14       Impact factor: 2.584

2.  Cough and Asthma.

Authors:  Akio Niimi
Journal:  Curr Respir Med Rev       Date:  2011-02

3.  A multicenter, prospective, observational study on montelukast monotherapy or montelukast-based combinations treating cough variant asthma.

Authors:  Jiangtao Lin; Zaiyi Wang; Chen Qiu; Zhen Wang; Shanping Jiang; Huaping Tang; Xuefen Wang; Zhongmin Qiu; Yong He; Jianping Zhao; Guochao Shi; Shenghua Sun; Limin Wang; Lin Chen; Jue Wang; Annhua Mao
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

4.  Small Airway Dysfunction in Cough Variant Asthma: Prevalence, Clinical, and Pathophysiological Features.

Authors:  Fang Yi; Ziyu Jiang; Hu Li; Chunxing Guo; Hankun Lu; Wei Luo; Qiaoli Chen; Kefang Lai
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

5.  Classification of chronic cough by systematic treatment cascade trial starting with beta agonist.

Authors:  Hideyasu Shimizu; Masamichi Hayashi; Yuji Saito; Yuki Mieno; Yasuo Takeuchi; Fumihiko Sasaki; Hiroki Sakakibara; Kensei Naito; Mitsushi Okazawa
Journal:  Cough       Date:  2013-02-07

6.  A retrospective study of clinical features of cough variant asthma in Chinese adults.

Authors:  Weiping Liu; Huaping Chen; Dehua Zhang; Feng Wu; Liqin Zhou
Journal:  Allergy Asthma Clin Immunol       Date:  2019-01-17       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.